Raymond James Financial Inc. bought a new stake in UiPath Inc. (NYSE:PATH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 433,165 shares of the company's stock, valued at approximately $5,506,000. Raymond James Financial Inc. owned about 0.08% of UiPath at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of UiPath during the 4th quarter worth about $71,191,000. Trexquant Investment LP purchased a new position in shares of UiPath in the 4th quarter valued at $15,611,000. Federated Hermes Inc. boosted its position in UiPath by 371.6% during the 4th quarter. Federated Hermes Inc. now owns 987,384 shares of the company's stock worth $12,550,000 after purchasing an additional 778,032 shares during the period. Vanguard Group Inc. increased its holdings in UiPath by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company's stock valued at $593,101,000 after purchasing an additional 576,458 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of UiPath by 73.8% during the fourth quarter. Russell Investments Group Ltd. now owns 1,118,774 shares of the company's stock worth $14,220,000 after purchasing an additional 475,133 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.
UiPath Stock Up 2.3 %
NYSE:PATH traded up $0.26 during trading hours on Friday, reaching $11.58. 10,860,748 shares of the company's stock were exchanged, compared to its average volume of 10,652,955. The company has a market capitalization of $6.39 billion, a P/E ratio of -72.38 and a beta of 1.04. UiPath Inc. has a 12 month low of $9.38 and a 12 month high of $20.95. The business's 50-day simple moving average is $11.26 and its two-hundred day simple moving average is $12.75.
Insider Transactions at UiPath
In other news, CAO Hitesh Ramani sold 12,500 shares of the company's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the sale, the chief accounting officer now directly owns 314,891 shares of the company's stock, valued at $3,208,739.29. This represents a 3.82 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 22.37% of the company's stock.
Analysts Set New Price Targets
Several research firms recently commented on PATH. Canaccord Genuity Group reduced their price target on UiPath from $19.00 to $14.00 and set a "buy" rating on the stock in a research report on Thursday, March 13th. Scotiabank reduced their target price on shares of UiPath from $15.00 to $12.00 and set a "sector perform" rating on the stock in a research report on Thursday, March 13th. Mizuho dropped their price target on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Evercore ISI cut their price objective on shares of UiPath from $16.00 to $12.00 and set an "in-line" rating on the stock in a report on Thursday, March 13th. Finally, UBS Group lowered their target price on UiPath from $14.00 to $10.00 and set a "sell" rating for the company in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $12.72.
Read Our Latest Analysis on UiPath
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.